Latest filing published 15 Jun 2026 for Pharma Mar, S.A.. Read the official filing
Based on 13 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Montserrat Andrade Detrell is a declared insider of Pharma Mar, S.A. (board member), with filings sourced from CNMV. The record holds 18 filings, for trades running from 24 January 2022 to 15 June 2026.
No open-market sale appears; the market trades are 17 purchases worth €157k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €6,711. Relative to company size, the median is 0.0004% of market cap (16 purchases with a known value). Clusters matter here: 13 out of 16 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. After 13 purchases with a full 90-day history, the hit rate stands at 38% and the median 90-day move at -9.2%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 15 June 2026, reports a transaction in Pharma Mar, S.A. The clock since the last published purchase (8 April 2025) now reads 558 days. The median gap between a trade and its publication by CNMV is 2 days. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations